Anticoagulation therapy in diabetic patients

Show simple item record Wessels, Pieter Frederik 2012-03-19T06:56:06Z 2012-03-19T06:56:06Z 2012-03
dc.description.abstract Diabetic patients have a high risk of developing arterial disease (coronary artery, cerebrovascular and peripheral arterial disease) and are therefore often given antiplatelet therapy. Although only retrospective studies suggest that diabetic patients are also prone to venous thrombo-embolism, many comorbid factors in the diabetic patient, such as heart failure, physical inactivity and atrial fibrillation increase the risk of venous thrombosis. A recent sub-analysis of the RECORD study examined the risk of hyperglycaemia during hip replacement, as a risk factor for postoperative venous thrombo-embolism. For these reasons, diabetic patients are also often given anticoagulant therapy. en_US
dc.description.uri en_US
dc.identifier.citation Wessels, PF 2012, 'Anticoagulation therapy in diabetic patients', South African Journal of Diabetes and Vascular Disease, vol. 9, no. 1, pp. 7-8. en_US
dc.identifier.issn 1811-6515
dc.language.iso en en_US
dc.publisher Clinics Cardiv en_US
dc.rights Clinics Cardiv en_US
dc.subject Anticoagulation therapy en_US
dc.subject Diabetic patients en_US
dc.subject Vascular disease en_US
dc.subject Atrial fibrillation (AF) en_US
dc.subject.lcsh Diabetic angiopathies en
dc.subject.lcsh Surgery -- Complications en
dc.subject.lcsh Hyperglycemia en
dc.title Anticoagulation therapy in diabetic patients en_US
dc.type Article en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record